Works matching AU MacLennan, S J

Results: 11

Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human.

Published in:

British Journal of Pharmacology, 2000, v. 129, n. 8, p. 1707

By:

Martin, R. S.;
Luong, L. A.;
Welsh, N. J.;
Eglen, R. M.;
Martin, G. R.;
MacLennan, S. J.

Publication type:

Article

Characterization of human recombinant α2A-adrenoceptors expressed in Chinese hamster lung cells using extracellular acidification rate changes.

Published in:

British Journal of Pharmacology, 2000, v. 129, n. 7, p. 1333, doi. 10.1038/sj.bjp.0703183

By:

MacLennan, S J;
Reynen, P H;
Martin, R S;
Eglen, R M;
Martin, G R

Publication type:

Article

Characterization of human recombinant α2A-adrenoceptors expressed in Chinese hamster lung cells using intracellular Ca2+ changes: evidence for cross-talk between recombinant α2A- and native α1-adrenoceptors

Published in:

British Journal of Pharmacology, 2000, v. 129, n. 7, p. 1339, doi. 10.1038/sj.bjp.0703184

By:

Reynen, P H;
Martin, G R;
Eglen, R M;
MacLennan, S J

Publication type:

Article

Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice.

Published in:

1999

By:

Zhu, Q-M;
Lesnick, J D;
Jasper, J R;
MacLennan, S J;
Dillon, M P;
Eglen, R M;
Blue, D R;
Blue, D R Jr

Publication type:

journal article

Antiphospholipid (Hughes) syndrome: description of population and health-related quality of life (HRQoL) using the SF-36.

Published in:

Lupus, 2015, v. 24, n. 2, p. 174, doi. 10.1177/0961203314551809

By:

Georgopoulou, S;
Efraimidou, S;
MacLennan, S J;
Ibrahim, F;
Cox, T

Publication type:

Article

Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors.

Published in:

1998

By:

MacLennan, S J;
Reynen, P H;
Kwan, J;
Bonhaus, D W

Publication type:

journal article

Characterization of α2-adrenoceptors mediating contraction of dog saphenous vein: identity with the human α2A subtype.

Published in:

British Journal of Pharmacology, 1997, v. 121, n. 8, p. 1721, doi. 10.1038/sj.bjp.0701296

By:

MacLennan, S. J.;
Luong, L. A.;
Jasper, J. R.;
To, Z. P.;
Eglen, R. M.

Publication type:

Article

Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).

Published in:

1997

By:

Martin, G R;
Robertson, A D;
MacLennan, S J;
Prentice, D J;
Barrett, V J;
Buckingham, J;
Honey, A C;
Giles, H;
Moncada, S

Publication type:

journal article

Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).

Published in:

British Journal of Pharmacology, 1997, v. 121, n. 2, p. 157, doi. 10.1038/sj.bjp.0701041

By:

Martin, G R;
Robertson, A D;
MacLennan, S J;
Prentice, D J;
Barrett, V J;
Buckingham, J;
Honey, A C;
Giles, H;
Moncada, S

Publication type:

Article

α2A-Adrenoceptors, Not I1-Imidazoline Receptors, Mediate the Hypotensive Effects of Rilmenidine and Moxonidine in Conscious Mice: In Vivo and In Vitro Studies.

Published in:

Annals of the New York Academy of Sciences, 1999, v. 881, n. 1, p. 287, doi. 10.1111/j.1749-6632.1999.tb09371.x

By:

ZHU, Q.-M.;
LESNICK, J. D.;
JASPER, J. R.;
MacLENNAN, S. J.;
DILLON, M. P.;
EGLEN, R. M.;
BLUE, D. R.

Publication type:

Article

Operational Studies of Synergistic Interactions with 5-HT1B/1D Receptors.

Published in:

Annals of the New York Academy of Sciences, 1998, v. 861, n. 1, p. 251, doi. 10.1111/j.1749-6632.1998.tb10207.x

By:

MARTIN, G. R.;
MacLENNAN, S. J.;
MAXWELL, M.;
SMITH, R. R.

Publication type:

Article

Works matching AU MacLennan, S J

Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human.

Characterization of human recombinant α<sub>2A</sub>-adrenoceptors expressed in Chinese hamster lung cells using extracellular acidification rate changes.

Characterization of human recombinant α<sub>2A</sub>-adrenoceptors expressed in Chinese hamster lung cells using intracellular Ca<sup>2+</sup> changes: evidence for cross-talk between recombinant α<sub>2A</sub>- and native α<sub>1</sub>-adrenoceptors

Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice.

Antiphospholipid (Hughes) syndrome: description of population and health-related quality of life (HRQoL) using the SF-36.

Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors.

Characterization of α<sub>2</sub>-adrenoceptors mediating contraction of dog saphenous vein: identity with the human α<sub>2A</sub> subtype.

Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).

Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT<sub>1B/1D</sub> receptor partial agonist, 311C90 (zolmitriptan).

α<sub>2A</sub>-Adrenoceptors, Not I<sub>1</sub>-Imidazoline Receptors, Mediate the Hypotensive Effects of Rilmenidine and Moxonidine in Conscious Mice: In Vivo and In Vitro Studies.

Operational Studies of Synergistic Interactions with 5-HT<sub>1B/1D</sub> Receptors.